Presidio Medical is a neurotechnology company developing advanced neuromodulation systems for the treatment of chronic pain. The company focuses on spinal cord stimulation approaches that dynamically adjust therapy in response to real-time physiological signals.

Its platform integrates implantable stimulation hardware with sensing and control algorithms to enable closed-loop modulation of spinal cord activity. By continuously adapting stimulation parameters, the system aims to improve pain relief consistency and reduce side effects compared with open-loop stimulation systems.

Presidio Medical’s technology is intended for clinical use in patients with chronic pain conditions who are candidates for spinal cord stimulation therapy. The company positions its platform as next-generation neuromodulation infrastructure that advances personalization and efficacy in pain management.